Acquired alpha-thalassemia most commonly develops in patients with myelodysplastic syndrome. It is caused by inactivating somatic mutations of the trans-acting chromatin-associated factor ATRX, which cause dramatic downregulation of alpha-globin gene expression.
Learn more here.